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Abstract
Background: Dose-response parameters based on clinical challenges are frequently used to
assess the health impact of protozoa in drinking water. We compare the risk estimates associated
with Giardia in drinking water derived from the dose-response parameter published in the literature
and the incidence of acute digestive conditions (ADC) measured in the framework of an
epidemiological study in a general population.
Methods: The study combined a daily follow-up of digestive morbidity among a panel of 544
volunteers and a microbiological surveillance of tap water. The relationship between incidence of
ADC and concentrations of Giardia cysts was modeled with Generalized Estimating Equations,
adjusting on community, age, tap water intake, presence of bacterial indicators, and genetic markers
of viruses. The quantitative estimate of Giardia dose was the product of the declared amount of
drinking water intake (in L) by the logarithm of cysts concentrations.
Results: The Odds Ratio for one unit of dose [OR = 1.76 (95% CI: 1.21, 2.55)] showed a very
good consistency with the risk assessment estimate computed after the literature dose-response,
provided application of a 20 % abatement factor to the cysts counts that were measured in the
epidemiological study. Doing so, a daily water intake of 2 L and a Giardia concentration of 10 cysts/
100 L, would yield an estimated relative excess risk of 12 % according to the Rendtorff model,
against 11 % when multiplying the baseline rate of ADC by the corresponding OR. This abatement
parameter encompasses uncertainties associated with germ viability, infectivity and virulence in
natural settings.
Conclusion:  The dose-response function for waterborne Giardia risk derived from clinical
experiments is consistent with epidemiological data. However, much remains to be learned about
key characteristics that may heavily influence quantitative risk assessment results.
Background
Infectious organisms resistant to disinfectants, such as
protozoa and viruses have caused several outbreaks
around the world, including in developed countries. The
most noticeable pathogen is Cryptosporidium which caused
the Milwaukee outbreak [1,2], and several episodes in the
US, the UK and Canada [3-6]; but Giardia lamblia, the
most common intestinal protozoan in the US, is also fre-
Published: 03 May 2006
BMC Public Health2006, 6:122 doi:10.1186/1471-2458-6-122
Received: 19 December 2005
Accepted: 03 May 2006
This article is available from: http://www.biomedcentral.com/1471-2458/6/122
© 2006Zmirou-Navier et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Public Health 2006, 6:122 http://www.biomedcentral.com/1471-2458/6/122
Page 2 of 9
(page number not for citation purposes)
quently reported in association with waterborne diseases
[7-9]. Cysts may be found in water as a result of fecal con-
tamination from both man and animal. Thus, protozoa
pose major challenges to design and maintenance of safe
water supplies. Microbial risk assessment is an important
tool to manage these risks because it allows water quality
standards and other management decisions to be based
on quantitative estimates [6,10,11]. The US-EPA, for
instance, has recommended that a treatment be provided
to ensure that populations are not subject to a yearly risk
of infection greater than 10-4 [7,12,13].
The quantitative microbiological risk assessment
approach is now well established [9,14-16]. Dose-
response functions have been proposed and reviewed for
waterborne pathogenic micro-organisms and for micro-
bial food safety [17-23]. The dose-response functions that
are currently used in risk assessment studies for protozoa
stem from clinical trials where adult healthy volunteers
have been exposed to known amounts of well character-
ized micro-organisms and followed to ascertain the devel-
opment of infection (faecal excretion, seroconversion).
Rendtorff (1954) [24] and Dupont et al (1995) [25] per-
formed controlled human feeding trials respectively for
Giardia lamblia and Cryptosporidium parvum (oo)cysts. The
exponential and the beta-Poisson model are commonly
used to describe these relationships [9,15,17,22]. They are
based on the assumptions of independent, single hit
action, and random distribution of the micro-organisms
in the inoculum. But it must be kept in mind that infec-
tion was measured by cyst excretion, not by symptoms.
This experimental approach is faced with severe ethical
restrictions that limit trials to healthy adult volunteers.
Also, issues regarding strain selection make generalization
of such data questionable [9]. Hence, variability related to
infectivity of different strains and to the immune response
of hosts could not be accommodated. These limitations
must be taken into account in risk assessment studies [7].
Epidemiological data offer the advantage of being based
on natural infection events, to bear on a variety of host
populations and on microorganisms that are found in real
life situations [9]. Epidemiological studies have already
been used to assess dose-response functions in the context
of outbreaks, but serious difficulties are encountered for
retrospective exposure assessment. For instance, a risk
assessment was conducted on the basis of disease risk
parameter estimated after the dose-response model devel-
oped by Dupont on healthy human volunteers [25], and
compared to the observed attack rates during the Milwau-
kee Cryptosporidium outbreak [1] to derive concentration
estimates of the pathogen in drinking water; the results
proved consistent with the levels that were found in ice
samples (1.4 oocysts/L versus 0.79 oocysts/L) [18,26].
Similar conclusions were drawn in another outbreak in
Bradford (UK) [15].
The present work uses epidemiological data collected in a
non epidemic setting and compares the risk estimates
derived from the published dose-response parameters for
Giardia to the observed incidence data in a general popu-
lation exposed to environmental strains of micro-organ-
isms.
Methods
The E.MI.R.A (Epidemiology and MIcrobial Risk Assess-
ment) study was carried out between October 1998 and
June 1999, in south-east France. It combined a daily epi-
demiological follow-up of digestive morbidity among a
panel of volunteers, and a microbiological surveillance of
drinking water. The E.MI.R.A study design has been
described in detail elsewhere [27-29].
Health survey
Briefly, volunteers have been recruited among communi-
ties supplied by 4 public water systems (groups 1 to 4),
specifically chosen for their raw water vulnerability : one
"pristine" groundwater located in a quarstic environment
(1); two vulnerable ground watersheds : a quarstic water-
shed (2), and an unprotected watershed exposed to live-
stock and community sewage (3); and one surface water :
a lake surrounded by human activities (4). Except in the
first group whose water was untreated, water was disin-
fected by chlorine only, hence allowing for presence of
chlorine-resistant pathogens despite absence of indicator
bacteria. Each participating family completed a self-
administrated daily questionnaire whereby all health
problems were to be registered. Morbidity data were
retrieved by telephone calls, following a daily 1/5th sam-
pling procedure (each working day of the week one fifth
of the families were called, thus allowing complete popu-
lation surveillance on a weekly frequency). This surveil-
lance scheme allowed a continuous description of
digestive morbidity incidence, along with outbreaks
detection. An "alert" threshold was based on a pilot study
data, and was defined as the occurrence of two incident
cases of acute digestive conditions in the same commu-
nity (but not in the same household) during the same 48
hours. To be considered as distinct, a lag greater than 48
hours was required between 2 episodes. A case of acute
digestive conditions (ADC) was defined as an episode of
abdominal pain, nausea, vomiting and/or diarrhea; a case
of diarrheic episode (DE) was an episode of diarrhea with
at least another digestive condition or fever; and a case of
gastro-enteritis (GE) was an episode of diarrhea with at
least another objective sign (fever or vomiting).
E.MI.R.A volunteers were also asked about their drinking
water consumption. Data were collected during a weekBMC Public Health 2006, 6:122 http://www.biomedcentral.com/1471-2458/6/122
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day and a week-end day by self-questionnaires that
explored tap and bottled water intake, type of usage of tap
water (cold/hot, with or without additional product) and
the place of water consumption (home, school, work).
Water quality survey
One tap water sample was collected monthly in each
study group. Additional tap water samples were also col-
lected in case the alert threshold was exceeded. Giardia
and Cryptosporidium were analyzed after filtration of 100 L
of water through a Gelman® Envirochek cartridge. The
analytical process used in this study is a modified protocol
from the method recommended by the US-EPA [30]; clar-
ification was done by ImmunoMagnetic Separation (IMS)
and (oo)cysts enumeration by laser-scanning cytometry
(Chemscan). The detection limit was 10 cysts/100 L and
the recovery rate averaged 50 percent [31]. Virological
quality of water was assessed using RT-PCR for detection
of enterovirus, rotavirus and astrovirus [32]. Bacterial
analyses were also done to control compliance with drink-
ing water quality regulations (absence of thermotolerant -
"faecal"- coliform in 100 ml, of faecal streptococci in 100
ml, and of spores of sulfite-reducing clostridia in 20 ml).
Statistical analysis
Due to the longitudinal design of the study, with repeti-
tive measurements on the same subjects, the relationship
between incidence of digestive morbidity and concentra-
tions of protozoa was modeled using Generalized Esti-
mating Equations (GEE), using a logistic link function.
Exposure was accommodated as a quantitative variable
where "dose" of ingested pathogens was the product of
declared individual tap water intake and Giardia concen-
trations (after Ln transformation). To improve exposure
ascription, the relationship was tested for different time
lags : more or less than 14 days around the corresponding
water sample, more or less seven days, and three days;
results of the latter exhibited greater associations and are
presented hereafter, meaning that only person-times of
observation (36% of the data) and cases (32%) that had
occurred within 3 days prior to or after the water samples
were considered for this analysis. Incidence of ADC rather
than DE or GE was chosen as the health endpoint because,
while less specific, it is a more sensitive measure of acute
digestive morbidity.
The dose-response function that was derived from our epi-
demiological data was compared to estimates of infec-
tious risks computed after the dose-response curve
established by Rendtorff on healthy human volunteers
[24]. The latter is an exponential dose-response curve : Pi
= 1 - exp (- r D), where Pi is the individual daily probabil-
ity of infection, r is an organism-specific infectivity param-
eter (host-microorganism interaction), and D is the daily
ingested dose of parasites. For Giardia, r = 0.02 (95 % con-
fidence interval : 0.0098–0.036) [10]. The dose is com-
puted as D = CV, where C is the concentration by liter of
cysts in tap water (Log transformed), and V is the individ-
ual's consumption of un-boiled cold water per day. This
model assumes that : (i) pathogens are randomly distrib-
uted at the exposure site; (ii) a fraction of the micro-
organisms ingested survive to cause infection; (iii) the sur-
vival of an individual organism is independent of the
presence of any other organism [33].
Illness is conditional on infection, and the probability of
becoming ill can be written as P(ill/dose) = P(ill/inf) *
P(inf/dose) [33], where P(inf/dose) is the probability of
infection supplied by the Rendorff model, and where
P(ill/inf) is the infectivity rate of the germ. Now, risk, ie
P(ill/dose), can be directly estimated from our epidemio-
logical data : Risk = Io × RRi, where RRi is the relative risk
associated with "dose" i (water intake × Ln [concentration
i]), and Io is the baseline incidence rate, i.e. when concen-
tration is zero. (Because the logistic link function was
used, RR was computed as an odds ratio ORi.) Thus, risks
attributable to increasing counts of Giardia can be com-
pared across the two estimation procedures. Both risk esti-
mates are not exactly identical, however, because not all
detected cysts in our study are viable and infectious, and
because not all infected subjects suffer acute digestive con-
ditions. For these reasons, direct comparison of the two
risk estimates might be misleading. Consequently, an
abatement factor was applied to the cysts counts used with
the Rendorff model risk estimate to take these differences
into account. Three hypothetical values of this abatement
factor are presented: 1/1 (meaning that all detected cysts
are infectious and cause digestive conditions), 1/2 (ie half
detected cysts are expected to be infectious and to cause
digestive conditions), and 1/5 (in other words, 80 % of
detected cysts are assumed non infectious or associated
with asymptomatic infections). The comparative analysis
was undertaken using Monte Carlo simulation with 5000
iterations and Latin Hypercube Sampling, using @Risk
3.5 (Palisade corporation). The Rendorff exponential
model r parameter was given a triangle distribution (most
likely r value = 0.0198, min = 0.0098, max = 0.036) [10].
The OR distribution values were derived from our study
results. Results are expressed in relative excess risks (in %),
where the baseline incidence rate Io is that observed when
the Giardia counts were 0/100 L.
Results
The epidemiological follow-up involved 544 volunteers
distributed across the 4 water groups, with 27.5 percent of
children (0–14 years old) and 12.1 percent subjects over
60 years old (Table 1). Only four "epidemic alerts" were
declared according to our definition, one true outbreak
being confirmed (group 3 in February 1999). Throughout
the study, the ADC incidence rate was 2.8 cases per per-BMC Public Health 2006, 6:122 http://www.biomedcentral.com/1471-2458/6/122
Page 4 of 9
(page number not for citation purposes)
son-year (95 % CI : 2.6–3.0), ranging from 2.0 cases per
person-year [1.6–2.5] to 4.7 [4.0–5.3] according to the
study group. The incidence rate of gastro-enteritis was 0.2
cases per person-year. The point estimate of the baseline
incident rate of ADC in absence of Giardia was 2.4 cases
per person-year. Detailed results on the study population
and the observed digestive morbidity are presented else-
where [27-29].
Total tap water intake follows a normal distribution and
varies according to season (average in winter = 1.6 L/d, SD
= 0.7 L/d; average in spring = 1.8 L/d, SD = 0.8 L/d). For
Monte Carlo simulation, we used our data set on un-
boiled tap water intake (0.8 L/d, 0.3 L/d). Detailed
description of daily drinking water consumption of
E.MI.R.A volunteers has been published [32].
Thirty two tap water samples were analyzed, provided by
the eight monthly routine sampling runs in each commu-
nity between November 1998 and June 1999. Four addi-
tional tap water samples were analyzed because of four
"epidemic alerts". Throughout the study, 30.6 percent (11
out of 36) of the samples were positive for at least one
protozoan : eight for Giardia, and three for Cryptosporid-
ium. The maximum concentration recorded was 110 cysts/
100 L for Giardia and 4 oocysts/100 L for Cryptosporidium.
Giardia  was found in tap water more often and with
higher levels than Cryptosporidium. Ten protozoa positive
samples out of 11 complied with bacterial criteria (table
2).
The odds ratio (OR) associated with one unit increase of
the Giardia "dose" is 1.76 (95 % CI : 1.21–2.55) after
adjustment on the following covariates : community, age,
compliance with bacterial criteria (dummy variable),
presence or absence of viral markers for enterovirus and
astrovirus (dummy variables) (table 3). Home character-
istics, gender, and presence of rotavirus or of Cryptosporid-
ium  (unfortunately,  Cryptosporidium  data were sparse)
showed no association with incidence of ADC. Enterovi-
rus exhibited a paradoxical 'protective' effect. This viral
family causes more neurologic than digestive conditions
[34; 35] and this statistical artefact is possibly due to
enterovirus being mostly present, during this study, when
more effective enteric pathogens (Giardia, astrovirus [29])
were absent, and conversely.
When comparing the risk estimates derived from the
Rendtorff model and from our observations, the best cor-
respondence is found with a 1/5 abatement factor : for
Table 2: Microbiological surveillance of tap water*
Group 1 Group 2 Group 3 Group 4
G CVBG CVBG CVBG CVB
Run 1 <<<-<<<+<<<-<<+-
Run 2 3 0 <<-1 0 <<-<<+-<<+-
Run 3 <<<-<<<-<<<- 1 1 0 <<-
Run 4 1 0 <<-2 0 <<-1 0 <+-<<+-
Run 5 <<<+<<+-<<+-<<+-
Run 6 <<<-<<<-<3<+<1+-




Alert 3 10 < + -
Alert 4 <<<-
* < = below detection limit. G = Giardia cysts counts (N per 100 L); C = Cryptosporidium oocysts counts (N per 100 L); V = no detection (<) or 
detection (+) of viral RNA (enterovirus, rotavirus, or astrovirus); B = compliance (-) or non compliance (+) with bacterial indicators' limit values
Table 1: Demographics of the population, by study group (n = 538)
Group 1 (n = 116) Group 2 (n = 100) Group 3 (n = 100) Group 4 (n = 222)
Sex ratio 1.04 0.79 0.87 1.05
Age structure (%)
< 15 years 27.6 20.0 26.0 31.5
15–59 64.6 59.0 61.0 58.6
>= 60 years 7.8 21.0 13.0 9.9BMC Public Health 2006, 6:122 http://www.biomedcentral.com/1471-2458/6/122
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hypothetical Giardia cysts counts ranging between 1 to
200/L (i.e. in the range of measured concentrations),
modeled risk values exceed the estimated incidence rate
by a factor spanning from 6.5 to 3.0 for a 1/1 abatement
factor, and from 3.3 to 1.5 for a 1/2 abatement factor; this
ratio did not exceed 1.6 for a 1/5 abatement factor, with
values close to 1 for low Giardia concentrations. Assum-
ing a daily water intake of 2 L and a Giardia concentration
of 10 cysts/100 L, the estimated relative excess risk would
be 12 % according to the Rendtorff model (with the 1/5
abatement factor), against 11 % applying the correspond-
ing OR to the baseline rate of ADC in absence of Giardia
cysts. Figure 1 exhibits risk estimates (expressed in percent
increase above the baseline incidence rate, with the 95 %
CI limits) from our study results and from the Rendtdorff
model values after we applied a 1/5 abatement factor to
the cysts counts; given this correction, it shows a good
agreement between the two slopes for contamination lev-
els in the domain of observed data (up to 110/L). The
underlying assumption in figure 1 is that 20 percent of the
detected cysts are capable to induce disease.
Discussion
The hazard that Giardia and Cryptosporidium pose to com-
munities supplied by surface water has been early recog-
nized by the US legislation, which requires a minimum of
three log removal/inactivation of Giardia  and two log
removal of Cryptosporidium [36,37]. These objectives were
derived in order to ensure that consumers would not be
exposed to a risk greater than one per 10 000 individuals
per year [11,19]. In the UK, the "Drinking Water Inspec-
torate" also takes into account Cryptosporidium  risks,
requiring a maximum level of 10 oocysts/100 L. UK regu-
lations also require that water providers perform a risk
assessment on their water treatment facilities and imple-
ment continuous monitoring for Cryptosporidium [38]. In
continental Europe, no rules exist to date for Giardia or
Cryptosporidium in drinking water [39].
While risk assessment is an important tool for manage-
ment of waterborne infectious risks, it is affected by sev-
eral uncertainties : there are knowledge gaps about
pathogens concentrations, and weaknesses in specifica-
tion of dose-response functions, amongst other factors
[8,9,40]. Dose-response data for infection with Giardia
lamblia were derived from an experiment on healthy adult
[24]. Now, healthy adults are not the most important
group from a public health perspective [8,41]. The
E.MI.R.A study included some sensitive subpopulations
(i.e., children, elderly subjects, pregnant women, but not
subjects with chronic diseases), which are excluded from
experiments for evident ethical reasons. Gerba et al
assessed that this subgroups represent about 20 percent of
the US population [42].
Our survey provided directly drinking water data; so we
did not need to formulate additional hypotheses on path-
ogens survival at early steps of the water supply chain, a
critical uncertainty factor in the waterborne microbial risk
assessment procedure [8,40]. The detection method we
used, however, does not differentiate between live, viru-
lent and non infectious micro-organisms; nor is it strictly
specific of human strains of parasites. On the other side,
the imperfect recovery of cysts from water samples may
allow for some cysts counts underestimation. The recovery
rate of 50 % of the technique we used had not been
assessed in a different framework than that of the present
study [31], but it stands in the range of values that were
published using the same U.S. Environmental Protection
Agency method 1623, in the low side [43]. Given these dif-
ferent factors, only a fraction of the detected parasites are
viable, infectious and virulent to humans. Several meas-
ures of viability have been proposed in the literature, such
as germ morphology, in vitro excystation assays, infectivity
tests in animal or cellular models [8,44,45]. No assay on
viability/infectivity was conducted within the E.MI.R.A
framework. Teunis et al reported that Giardia cysts shed-
ding might occur at very low infectious doses (3–10 cysts)
[8]. In our study, Giardia cysts were found at non negligible
levels in tap water (10, 20, 30 and 110 cysts per 100 L).
Other critical issues in exposure assessment should also be
discussed. We hypothesised, in this analysis, that one water
sample represented the average parasitical quality of water
during 7 days (day of sampling and 3 days about). Backing
this assumption, a Canadian study showed small differ-
ences in Giardia cysts counts along consecutive days [46]. It
was conducted in highly polluted surface water, however,
and whether this observation applies in the low contamina-
tion level of the present study is unclear. While we are not
aware of published papers describing short term variability
Table 3: Results of the multivariate analysis
Variable name Odds Ratio 95% CI P value
Study group (class)
2 0.83 [0.65–1.06] 0.13
3 1.19 [1.01–1.39] 0.03
4 0.84 [0.76–0.93] 0.001
Age (class)
15–59 years-old 0.95 [0.85–1.06] 0.36
> 60 years-old 0.95 [0.82–1.11] 0.54
Bacterial Compliance 0.81 [0.64–1.02] 0.08
Enterovirus RNA (+/-) 0.61 [0.46–0.80] 0.0003
Astrovirus RNA (+/-) 1.49 [1.16–1.90] 0.002
V*Ln (Giardia)* 1.76 [1.21–2.55] 0.003
* combination of tap water intake and Giardia counts : V*Ln(Giardia) 
Other non significant variables in the model : Gender, Socio-
economic status, Housing, Rotavirus RNA (+/-) and Cryptosporidium 
countsBMC Public Health 2006, 6:122 http://www.biomedcentral.com/1471-2458/6/122
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of (oo)cysts concentrations in ground or surface water used
for drinking water, seasonality has been assessed in several
studies, with uneven findings according to watershed vul-
nerability and to the time pattern of contaminants dis-
charge into surface water [47-51]. Hence, the time
representativity of our water samples is not fully character-
ised despite our repetitive sampling. The latency for Giardia
infection and disease is commonly reported to be com-
prised between one and 14 days. Thus, the seven days mor-
bidity period we chose might be incomplete; it showed the
best statistical associations, however, compared to 2 weeks
or one month sampling frames. Exposure to waterborne
pathogens depends upon infectious micro-organisms con-
centration, but also on the amount of water that is ingested.
Most risk assessment studies use 2 L as the default value for
daily drinking water intake. Here, we applied the consump-
tion values that were declared by the study volunteers for
un-boiled tap water. Finally, one cannot rule out some
degree of confounding of the effect attributed to Giardia due
to concomitant presence of other pathogens, a situation
that occurred during the true outbreak that was observed
during the study. It should be noted that our risk estimates
for Giardia are adjusted for other measured concomitant
pathogens. In a recent report of the large Bergen waterborne
giardiasis outbreak, Norway, the authors underline how dif-
ficult it may be to assign cases to a given pathogen, even
using sophisticated Giardia and Cryptosporidium genotyping,
both of cases stools and water samples [52,53]. The two
protozoans were not found concomitantly in our study,
however, but this might be partly explained by imperfect
recoveries.
It is reasonable to think that the association between
digestive morbidity and Giardia exposure differs accord-
ing to age. Unfortunately, we could not assess this hetero-
geneity, because of lack of statistical power, the reason
why we split our data in only three age categories. The lit-
erature does not provide such information either and this
calls for further research. Our risk estimates for Giardia are
consistent with those derived after the Rendtorff model
provided that we down-weight the measured germ counts
by a 1/5 factor. This parameter encompasses several
dimensions: (i) the recovery rate of the analytical tech-
niques is not 100 percent (with the Gelman® protocol
used here this rate averages 50 percent); (ii) some detected
cysts might be non viable and non infectious to humans;
(iii) some infected subjects might be asymptomatic. It is
difficult, and out of the scope of this study, to devise what
Relative excess risk (in %, and 95% confidence intervals) attributable to Giardia counts in tap water : comparison of results  derived from the E.MI.R.A observations (in blue) and from the experimental exponential model (in red) after application of a 20  % abatement factor Figure 1
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role these different factors play, in the net estimated 20
percent weigh. For instance, one could hypothesise that
the incidence rate could have been greater in this general
population, because the viability and infectivity character-
istics of the pathogens in the natural environment might
be larger than those assayed in the Rentdorff experience.
In their 1991 work, Le Chevallier et al had found that 13.3
percent of the detected cysts had a viable morphology
[44]. A probability of disease, when infected, of about 70
percent (95 % CI : 35–100) has been assessed for Crypt-
osporidium [54] and 37 % of oocysts found in six US water-
sheds showed viable and infectious [36]. For Giardia,
symptomatic infection proportions have been reported
ranging between 50 % and 67 %, and as high as 91 % [7].
On the other hand, there might be some degree of popu-
lation immunity, associated with the prevalence of cysts
in drinking water [55,56]
While substantial efforts are ongoing to improve risk
assessment of Cryptosporidium, because of its well estab-
lished virulence for immunocompromised subjects, fewer
risk assessment data concern Giardia. The E.MI.R.A study
had been designed to deal with the 2 protozoa, but pres-
ence of Cryptosporidium in tap water of our French com-
munities was too rare an event for analysis. Evidence of
consistency between estimated and observed germ counts
after the Milwaukee Cryptosporidium outbreak also gives
some support to the validity of risk parameters that were
computed through clinical infection assays; we suggest,
however, that studies along the same rationale as the
E.MI.R.A. study could be designed to assess dose-response
functions for this pathogen in a non-epidemic context,
because waterborne exposure to protozoa may result in
sporadic cases and not necessarily in outbreak situations,
as it was seen in the present study. In an Australian study
in Sydney, raw and finished water were contaminated by
Cryptosporidium and Giardia without discernable increases
in illness in the general population [57]. It is well known,
however, that only a very small fraction of individuals
with acute digestive conditions ask for medical attention
and are adequately diagnosed and registered [5].
Conclusion
Quantitative microbial risk assessment is a useful tool for
the management of waterborne infectious risks. This
study, conducted in a general population in a natural set-
ting, suggests that the exponential model for waterborne
Giardia risk derived from clinical experiments is consistent
with epidemiological data. However, much remains to be
learned about key characteristics that may heavily influ-
ence quantitative risk assessment results, such as germ via-
bility, infectivity and virulence, or analytical recovery
performances in natural environments.
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